The currently available anti-Toxoplasma agents have serious limitations. This systematic
review was performed to evaluate drugs and new compounds used for the treatment of …

The protozoan Toxoplasma gondii, an obligate intracellular parasite, is an etiological agent
of human and animal toxoplasmosis. Treatment regimens for T. gondii-infected patients …

Plasmodium spp. parasites that cause malaria disease remain a significant global-health
burden. With the spread of parasites resistant to artemisinin combination therapies in …

Toxoplasmosis constitutes a global infection caused by oblige intracellular apicomplexan
protozoan parasite Toxoplasma gondii. Although often asymptomatic, infection can result in …

African trypanosomes are sustained in the bloodstream of their mammalian hosts by their
extreme capacity for antigenic variation. However, for life cycle progression, trypanosomes …

This study evaluated the anti-Toxoplasma gondii potential of gold, silver, and platinum
nanoparticles (NPs). Inorganic NPs (0.01–1,000 µg/mL) were screened for antiparasitic …

Toxoplasma gondii severely threaten the health of immunocompromised patients and
pregnant women as this parasite can cause several disease, including brain and eye …

Toxoplasma gondii is a highly prevalent protozoon that can infect all warm-blooded animals,
including humans. It is frequently used as an Apicomplexan parasite model in research. In …

Toxoplasmosis is a common parasitic disease caused by Toxoplasma gondii. Limitations of
available treatments motivate the search for better therapies for toxoplasmosis. In this study …

Abstract The Trypanosoma and Toxoplasma spp, are etiological agents of diseases capable
of causing significant morbidity, mortality and economic burden, predominantly in …